Gavriola et al. [43] concluded that mice that were knocked out for PPARγ, specifically in the liver, had worsened hyperlipidemia, triglyceride clearance and muscle insulin resistance when compared to mice with the gene normally expressed. Here, PPARG is linked to hyperlipidemia.